secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001558370-23-001751
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health Q4 revenue up 15% to $637.7M; net loss of $3.81B on $3.77B goodwill impairment
--------------------------------------------------------------------------------

- Full-year 2022 revenue $2.41B (+18% YoY); net loss $13.66B ($84.60/share) driven by $13.4B non-cash goodwill impairment.
- Q4 adjusted EBITDA $94.1M (+22% YoY); full-year adjusted EBITDA $246.5M (-8% YoY).
- BetterHelp segment Q4 revenue $277.0M (+29% YoY); Integrated Care Q4 revenue $357.1M (+6% YoY).
- Full-year free cash flow $16.5M vs $130.1M in 2021; cash position $918.2M at Dec 31, 2022.
- Q1 2023 revenue guidance $610-625M; full-year 2023 revenue $2.55-2.675B, adjusted EBITDA $275-325M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837023001751/0001558370-23-001751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837023001751/tdoc-20230222x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-001751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer